Skip to main content
Premium Trial:

Request an Annual Quote

Larry Tiffany, Dennis Rossi, Illumina, Duke University's Center for HIV/AIDS Vaccine Immunology

Premium

People in the News

Larry Tiffany has joined Gene Logic as senior vice president and interim general manager of its genomics division, according to a June 27 Securities and Exchange Commission filing.

Tiffany, who previously served as vice president of international business development at Gene Logic, will replace Dennis Rossi, who left the company last month.

According to the filing, Tiffany's employment agreement began June 21 and runs through Aug. 31. The contract can be extended by mutual agreement. On an annualized basis, Tiffany will be paid $300,000.

 

New Product Watch

Illumina last week launched its Sentrix HumanHap650Y BeadChip, that covers all four populations studied by the International HapMap Project including the Yoruba of Nigeria.

The Yoruba population is very genetically diverse, and demands a higher number of SNPs than less-diverse, younger populations, like Europeans, to achieve equivalent genomic coverage, Illumina said.

The HumanHap650Y BeadChip contains over 650,000 SNP markers. The company said that the chip will be used by Duke University's Center for HIV/AIDS Vaccine Immunology to analyze a 2,000-sample cohort of HIV-exposed African individuals that are and are not infected with the virus in order to identify gene variants that confer either resistance or susceptibility to infection.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.